BACKGROUND: Chromosomal instability is observed in a wide spectrum of human cancer syndromes. However, to date, little is known of the characteristic genetic changes in sporadic neuroendocrine tumours of the gastroenteropancreatic system. AIMS AND METHOD: We have studied copy number aberrations (CNAs) in 26 sporadic neuroendocrine tumours of the enteropancreatic system (12 foregut and 14 midgut tumours) by comparative genomic hybridisation (CGH), allowing simultaneous evaluation of the entire tumour genome. RESULTS: Nearly all tumours (25/26; that is, 96%) showed chromosomal imbalances, including full chromosomal aneuploidies, losses and gains of chromosome arms, interstitial deletions, and amplifications. Whereas gains of chromosomes 4, 5, and 19 were found in both foregut and midgut tumours, gains of chromosomes 20q (58%), 19 (50%), as well as 17p (50%), and partial losses of chromosomes 1p (42%), 2q (42%), 3p, 4q, and 6q (25% each) were frequently observed only in foregut tumours. In contrast, midgut tumours displayed less CNAs. Gains were detected for chromosomes 17q and 19p (57%). Most frequent losses affected chromosomes 18 (43%) and 9p (21%). CONCLUSIONS: The results of our CGH analyses revealed new distinct candidate regions in the human genome associated with sporadic neuroendocrine tumours. Some of the genetic alterations were shared by foregut and midgut tumours while others discriminated between the two groups. Thus our results allude to the involvement of identical as well as discriminative genetic loci in tumorigenesis and progression of neuroendocrine neoplasms of the foregut and midgut. Based on these findings potential new candidate genes will be discussed.
BACKGROUND: Chromosomal instability is observed in a wide spectrum of humancancer syndromes. However, to date, little is known of the characteristic genetic changes in sporadic neuroendocrine tumours of the gastroenteropancreatic system. AIMS AND METHOD: We have studied copy number aberrations (CNAs) in 26 sporadic neuroendocrine tumours of the enteropancreatic system (12 foregut and 14 midgut tumours) by comparative genomic hybridisation (CGH), allowing simultaneous evaluation of the entire tumour genome. RESULTS: Nearly all tumours (25/26; that is, 96%) showed chromosomal imbalances, including full chromosomal aneuploidies, losses and gains of chromosome arms, interstitial deletions, and amplifications. Whereas gains of chromosomes 4, 5, and 19 were found in both foregut and midgut tumours, gains of chromosomes 20q (58%), 19 (50%), as well as 17p (50%), and partial losses of chromosomes 1p (42%), 2q (42%), 3p, 4q, and 6q (25% each) were frequently observed only in foregut tumours. In contrast, midgut tumours displayed less CNAs. Gains were detected for chromosomes 17q and 19p (57%). Most frequent losses affected chromosomes 18 (43%) and 9p (21%). CONCLUSIONS: The results of our CGH analyses revealed new distinct candidate regions in the human genome associated with sporadic neuroendocrine tumours. Some of the genetic alterations were shared by foregut and midgut tumours while others discriminated between the two groups. Thus our results allude to the involvement of identical as well as discriminative genetic loci in tumorigenesis and progression of neuroendocrine neoplasms of the foregut and midgut. Based on these findings potential new candidate genes will be discussed.
Authors: R Chakrabarti; E S Srivatsan; T F Wood; P J Eubanks; S A Ebrahimi; R A Gatti; E Passaro; M P Sawicki Journal: Genes Chromosomes Cancer Date: 1998-06 Impact factor: 5.006
Authors: B Terris; M Meddeb; A Marchio; G Danglot; J F Fléjou; J Belghiti; P Ruszniewski; A Bernheim Journal: Genes Chromosomes Cancer Date: 1998-05 Impact factor: 5.006
Authors: J Richter; F Jiang; J P Görög; G Sartorius; C Egenter; T C Gasser; H Moch; M J Mihatsch; G Sauter Journal: Cancer Res Date: 1997-07-15 Impact factor: 12.701
Authors: D J Clarke; J F Giménez-Abián; H Tönnies; H Neitzel; K Sperling; C S Downes; R T Johnson Journal: Proc Natl Acad Sci U S A Date: 1998-01-06 Impact factor: 11.205
Authors: P Muscarella; W S Melvin; W E Fisher; J Foor; E C Ellison; J G Herman; W J Schirmer; C L Hitchcock; B R DeYoung; C M Weghorst Journal: Cancer Res Date: 1998-01-15 Impact factor: 12.701
Authors: Simon Schimmack; Bernhard Svejda; Benjamin Lawrence; Mark Kidd; Irvin M Modlin Journal: Langenbecks Arch Surg Date: 2011-01-28 Impact factor: 3.445
Authors: Rony A François; Kyungah Maeng; Akbar Nawab; Frederic J Kaye; Steven N Hochwald; Maria Zajac-Kaye Journal: J Natl Cancer Inst Date: 2015-05-12 Impact factor: 13.506
Authors: Mohammad Y Zaidi; Alexandra G Lopez-Aguiar; Jeffrey M Switchenko; Joseph Lipscomb; Valentina Andreasi; Stefano Partelli; Adriana C Gamboa; Rachel M Lee; George A Poultsides; Mary Dillhoff; Flavio G Rocha; Kamran Idrees; Clifford S Cho; Sharon M Weber; Ryan C Fields; Charles A Staley; Massimo Falconi; Shishir K Maithel Journal: Ann Surg Date: 2019-09 Impact factor: 12.969
Authors: Christina L Roland; Lee F Starker; Y Kang; Deyali Chatterjee; Jeannelyn Estrella; Asif Rashid; Matthew H Katz; Thomas A Aloia; Jeffrey E Lee; Arvind Dasari; James C Yao; Jason B Fleming Journal: Surgery Date: 2016-11-03 Impact factor: 3.982
Authors: Irvin M Modlin; Steven F Moss; Daniel C Chung; Robert T Jensen; Elizabeth Snyderwine Journal: J Natl Cancer Inst Date: 2008-09-09 Impact factor: 13.506
Authors: Michaela S Banck; Rahul Kanwar; Amit A Kulkarni; Ganesh K Boora; Franziska Metge; Benjamin R Kipp; Lizhi Zhang; Erik C Thorland; Kay T Minn; Ramesh Tentu; Bruce W Eckloff; Eric D Wieben; Yanhong Wu; Julie M Cunningham; David M Nagorney; Judith A Gilbert; Matthew M Ames; Andreas S Beutler Journal: J Clin Invest Date: 2013-05-15 Impact factor: 14.808